Attached files
file | filename |
---|---|
EX-31.2 - INTEGRATED BIOPHARMA INC | exhibit31_2.htm |
EX-32.1 - INTEGRATED BIOPHARMA INC | exhibit32_1.htm |
EX-31.1 - INTEGRATED BIOPHARMA INC | exhibit31_1.htm |
10-Q - INTEGRATED BIOPHARMA INC | inb10q_20100331.htm |
Exhibit
32.2
CERTIFICATION OF PERIODIC
REPORT
As
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In
connection with the Quarterly Report on Form 10-Q for the third quarter ended
March 31, 2010 of Integrated BioPharma, Inc. (the “Company”) as filed with the
Securities and Exchange Commission on the date hereof (the “Report”), Dina L.
Masi, the Senior Vice President and Chief Financial Officer of Integrated
BioPharma, Inc. certifies, pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to
her knowledge:
(1)
|
the
Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d));
and
|
(2)
|
the
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
|
This
certification accompanies the Report pursuant to Section 906 of Sarbanes-Oxley
Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley
Act of 2002, be deemed filed by the Company for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended.
A signed
original of this written statement has been provided to the Company and will be
retained by the Company and furnished to the Securities and Exchange Commission
or its staff upon request.
Date: May 19, 2010 | By: | /s/ Dina L. Masi | |
Dina L. Masi | |||
Chief Financial Officer & Senior Vice President |